Brought to you by

Stryker to acquire Entellus Medical for $24 per share
04 Oct 2018
Executive Summary
Stryker Corp. agreed to acquire Entellus Medical Inc. (minimally invasive ENT products) for $24 per share in cash (47% premium to prior 10-day stock trading average), or a total equity value of approximately $662mm (enterprise value of $658.1mm accounting for net debt).
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com